Clinical and genetic heterogeneity in black patients with homozygous ß-thalassemia from the Southeastern United States

Abstract

The presence of various substitutions and deletions resulting in ß-thalassemia was studied in 19 black patients with homozygous ß-thalassemia and in numerous relatives; all patients were from Georgia, South Carolina, and Alabama. Methodology included gene mapping, amplification of genomic DNA with Taq polymerase, identification of known nucleotide substitutions or a single nucleotide deletion through hybridization with synthetic oligonucleotides, cloning and sequencing of a ß-globin gene, and sequencing of amplified genomic DNA. Of the 38 chromosomes tested, 21 (55%) had the A ? G substitution at nt -29, eight (21%) had the C ? T substitution at nt -88, three (8%) had the substitution at codon 24, while one each of the following abnormalities were also detected frameshift at codon 6, a C ? A mutation at nt 848 of the ßIVS-II (new), an A ? T mutation at codon 61 (new), a deletion of 1.35 kilobases including the 5' end of ß, a (G)?((A)?dß)°-thalassemia, and one thalassemia determinant that remained unidentified. The C ? A mutation at nt 848 of IVS-II occurred at a position 3 nucleotides 5' to the third exon, adjacent to the invariant Ag dinucleotide of the acceptor sequence. The A ? T mutation in codon 61 (AAG ? TAG) resulted in the creation of a stop codon and thus in ¯°-thalassemia. The various mutations occurred on chromosomes with different haplotypes; however, chromosomes with a specific mutation but with different haplotypes belonged to one specific framework, which suggested that crossovers were responsible for these different types. Hemoglobin (Hb) F levels wre generally high (55% to 75% with 98.5% in one patient with ß°/ß°); a few patients with specific haplotypes and an a-thalassemia-2 heterozygosity had a lower Hb F level. The (G)? in the Hb F was consistently high when the C ? T mutation occurred at nt -158 to the Cap site of the (G)?-globin gene; seven patients with +/+ at this site had an average (G)? of 73.8%, eight patients with +/- had 64.8%, and one patient with -/- had 34.2%. Variations in hematologic values and in Hb F, (G)?, and Hb A2 levels of relatives with a ß-thalassemia heterozygosity depended to some extent on the types of mutations or deletions and on the haplotypes of the chromosomes with the ß-thalassemia determinant.